Praxis Precision Medicines Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 3.01, 317.12, 1079.19, 2090.94, 3280.96 ], "ebit_estimate": [ -476.99, -342.35, 232.52, 1191.46, 2152.71 ], "ebitda_estimate": [ -452.64, -362.06, -62.62, 315.28, 919.28 ], "net_income_estimate": [ -442.6, -331.92, 238.59, 992.42, 1996.14 ], "per_share_eps_estimate": [ -15.08, -10.53, 9.19, 34.78, 54.53 ], "eps_nri_estimate": [ -15.08, -10.5, 7.55, 30.38, 47.83 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 39.22, 32.73, 42.66, 63.93, 112.31 ], "pretax_income_estimate": [ -441.54, -301.7, 286.67, 990.87, 2199.36 ], "operating_cash_flow_per_share_estimate": [ -10.29, -5.63, 3.82, 17.58, 41.23 ], "roa_estimate": [ -36.2, -17.6, 7.1, 28.3, 45.2 ], "roe_estimate": [ -38.7, -19.3, 8, 31.3, 48.6 ], "gross_margin_estimate": [ 69.25, 92.42, 92.23, 92.37, 92.75 ], "operating_cash_flow_estimate": [ -297.22, -162.62, 110.34, 507.78, 1190.89 ], "pettm_estimate": [ 0, 0, 35.23, 9.31, 5.94 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 40.39, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, 0.11, 2.91, 16.9, 34.96, 65.89, 137.03, 84.47 ], "ebit_estimate": [ -114.24, -125.72, -134.88, -152.71, -141.17, -118.3, -72.13, -92.04 ], "ebitda_estimate": [ -111.8, -117.34, -117.69, -135.27, -128.84, -125.86, -109.94, -91.75 ], "net_income_estimate": [ -106.22, -117.8, -127.18, -144.64, -134.18, -113.2, -72.6, -86.04 ], "per_share_eps_estimate": [ -3.66, -3.97, -4.19, -4.54, -4.2, -3.49, -1.59, -2.51 ], "eps_nri_estimate": [ -3.66, -3.97, -4.19, -4.54, -4.2, -3.49, -1.59, -2.51 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 44.32, 40.85, 37.98, 34.82, 32.02, 29.82, 29.06, null ], "pretax_income_estimate": [ -106.03, -116.85, -124.51, -137.57, -128.04, -107.56, -47.05, -86.04 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, 92, 91, 91, 91, 91, 91, 92 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 40.39, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }